Characterization of Silver Nanoparticles in Cell Culture Medium Containing Fetal Bovine Serum

Langmuir

Volumn 31, Issue 24, 2015, Pages 6842-6852

  Hansen, Ulf ^a   Thünemann, Andreas F ^a  

^a BAM FEDERAL INSTITUTE FOR MATERIALS RESEARCH AND TESTING   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BODY FLUIDS; CELL CULTURE; CHARACTERIZATION; CONSUMER PRODUCTS; ELECTROPHORESIS; FRACTIONATION; LIGHT SCATTERING; LIQUID CHROMATOGRAPHY; MAMMALS; METAL IONS; NANOPARTICLES; POLYETHYLENE GLYCOLS; POLYETHYLENES; RISK ASSESSMENT; X RAY SCATTERING;

ASYMMETRICAL FLOW FIELD FLOW FRACTIONATION; CELL CULTURE MEDIUMS; CERTIFIED REFERENCE MATERIALS; PARTICLE CHARACTERIZATION; PEPTIDE IDENTIFICATION; POLY VINYL PYRROLIDONE; SILVER NANOPARTICLES; TOXICOLOGICAL EFFECTS;

SILVER;

CULTURE MEDIUM; METAL NANOPARTICLE; SILVER;

ANIMAL; BOVINE; CACO 2 CELL LINE; CELL SURVIVAL; CHEMICAL STRUCTURE; CHEMISTRY; CULTURE MEDIUM; DOSE RESPONSE; DRUG EFFECTS; HUMAN; PARTICLE SIZE; PHARMACOLOGY; SERUM; STRUCTURE ACTIVITY RELATION;

ANIMALS; CACO-2 CELLS; CATTLE; CELL SURVIVAL; CULTURE MEDIA; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; METAL NANOPARTICLES; MOLECULAR STRUCTURE; PARTICLE SIZE; SERUM; SILVER; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 84934977396     PISSN: 07437463     EISSN: 15205827     Source Type: Journal    
DOI: 10.1021/acs.langmuir.5b00687     Document Type: Article

References (53)

1. Rejeski, D. Nanotechnology and Consumer Products; Project on Emerging Nanotechnologies, Woodrow Wilson International Center for Scholars: Bethesda, MD, 2009; p 12.
2. Rogers, K. R.; Bradham, K.; Tolaymat, T.; Thomas, D. J.; Hartmann, T.; Ma, L. Z.; Williams, A. Alterations in physical state of silver nanoparticles exposed to synthetic human stomach fluid Sci. Total Environ. 2012, 420, 334-339
3. Potočnik, J. Commission Recommendation of 18 October 2011 on the Definition of Nanomaterial Text with EEA Relevance; European Commision: Brussels, 2011; p 38-40.
4. Karmali, P. P.; Simberg, D. Interactions of nanoparticles with plasma proteins: Implication on clearance and toxicity of drug delivery systems Expert Opin. Drug Delivery 8, 343-357.
5. Nel, A. E.; Madler, L.; Velegol, D.; Xia, T.; Hoek, E. M. V.; Somasundaran, P.; Klaessig, F.; Castranova, V.; Thompson, M. Understanding biophysicochemical interactions at the nano-bio interface Nat. Mater. 2009, 8, 543-557
6. Maiorano, G.; Sabella, S.; Sorce, B.; Brunetti, V.; Malvindi, M. A.; Cingolani, R.; Pompa, P. P. Effects of cell culture media on the dynamic formation of protein-nanoparticle complexes and influence on the cellular response ACS Nano 2010, 4, 7481-7491
7. Casals, E.; Pfaller, T.; Duschl, A.; Oostingh, G. J.; Puntes, V. Time evolution of the nanoparticle protein corona ACS Nano 2010, 4, 3623-3632
8. Milani, S.; Bombelli, F. B.; Pitek, A. S.; Dawson, K. A.; Radler, J. Reversible versus irreversible binding of transferrin to polystyrene nanoparticles: Soft and hard corona ACS Nano 2012, 6, 2532-2541
9. Beer, C.; Foldbjerg, R.; Hayashi, Y.; Sutherland, D. S.; Autrup, H. Toxicity of silver nanoparticles - Nanoparticle or silver ion? Toxicol. Lett. 2011, 208, 286-292
10. Andrlik, I. Einfluss der nichtionischen Tenside Tween 20, Tween 80 und Pluronic F-68 auf die Interaktion von Nanopartikeln mit Caco-2 Einzelzellen. Diploma Thesis; University of Wien, Vienna, Austria, 2008.
11. Baier, G.; Costa, C.; Zeller, A.; Baumann, D.; Sayer, C.; Araujo, P. H. H.; Mailander, V.; Musyanovych, A.; Landfester, K. BSA adsorption on differently charged polystyrene nanoparticles using isothermal titration calorimetry and the influence on cellular uptake Macromol. Biosci. 11, 628-638.
12. Wang, F. J.; Yu, L.; Monopoli, M. P.; Sandin, P.; Mahon, E.; Salvati, A.; Dawson, K. A. The biomolecular corona is retained during nanoparticle uptake and protects the cells from the damage induced by cationic nanoparticles until degraded in the lysosomes Nanomedicine (N. Y., NY, U. S.) 2013, 9, 1159-1168
13. Lesniak, A.; Fenaroli, F.; Monopoli, M. R.; Aberg, C.; Dawson, K. A.; Salvati, A. Effects of the presence or absence of a protein corona on silica nanoparticle uptake and impact on cells ACS Nano 2012, 6, 5845-5857
14. Kim, J. A.; Salvati, A.; Aberg, C.; Dawson, K. A. Suppression of nanoparticle cytotoxicity approaching in vivo serum concentrations: Limitations of in vitro testing for nanosafety Nanoscale 2014, 6, 14180-14184
15. Ahamed, M.; AlSalhi, M. S.; Siddiqui, M. K. J. Silver nanoparticle applications and human health Clin. Chim. Acta 2010, 411, 1841-1848
16. Gopinath, P.; Gogoi, S. K.; Sanpui, P.; Paul, A.; Chattopadhyay, A.; Ghosh, S. S. Signaling gene cascade in silver nanoparticle induced apoptosis Colloids Surf. B. 77, 240-245.
17. Hsin, Y. H.; Chena, C. F.; Huang, S.; Shih, T. S.; Lai, P. S.; Chueh, P. J. The apoptotic effect of nanosilver is mediated by a ROS- and JNK-dependent mechanism involving the mitochondrial pathway in NIH3T3 cells Toxicol. Lett. 2008, 179, 130-139
18. Hussain, S. M.; Hess, K. L.; Gearhart, J. M.; Geiss, K. T.; Schlager, J. J. In vitro toxicity of nanoparticles in BRL 3A rat liver cells Toxicol. In Vitro 2005, 19, 975-983
19. Bouwmeester, H.; Dekkers, S.; Noordam, M. Y.; Hagens, W. I.; Bulder, A. S.; de Heer, C.; ten Voorde, S.; Wijnhoven, S. W. P.; Marvin, H. J. P.; Sips, A. Review of health safety aspects of nanotechnologies in food production Regul. Toxicol. Pharmacol. 2009, 53, 52-62
20. Foldbjerg, R.; Olesen, P.; Hougaard, M.; Dang, D. A.; Hoffmann, H. J.; Autrup, H. PVP-coated silver nanoparticles and silver ions induce reactive oxygen species, apoptosis and necrosis in THP-1 monocytes Toxicol. Lett. 2009, 190, 156-162
21. Hassellov, M.; Readman, J. W.; Ranville, J. F.; Tiede, K. Nanoparticle analysis and characterization methodologies in environmental risk assessment of engineered nanoparticles Ecotoxicology 2008, 17, 344-361
22. Bohmert, L.; Girod, M.; Hansen, U.; Maul, R.; Knappe, P.; Niemann, B.; Weidner, S. M.; Thunemann, A. F.; Lampen, A. Analytically monitored digestion of silver nanoparticles and their toxicity on human intestinal cells Nanotoxicology 2014, 8, 631-42
23. Thunemann, A. F.; Knappe, P.; Bienert, R.; Weidner, S. Online coupling of field-flow fractionation with SAXS and DLS for polymer analysis Anal. Methods 2009, 1, 177-182
24. Norde, W.; Gage, D. Interaction of bovine serum albumin and human blood plasma with PEO-tethered surfaces: Influence of PEO chain length, grafting density, and temperature Langmuir 2004, 20, 4162-4167
25. Torchilin, V. P.; Trubetskoy, V. S. Which polymers can make nanoparticulate drug carriers long-circulating? Adv. Drug Delivery Rev. 1995, 16, 141-155
26. Treuel, L.; Malissek, M.; Grass, S.; Diendorf, J.; Mahl, D.; Meyer-Zaika, W.; Epple, M. Quantifying the influence of polymer coatings on the serum albumin corona formation around silver and gold nanoparticles J. Nanopart. Res. 2012, 14.
27. Prestel, H.; Niessner, R.; Panne, U. Increasing the sensitivity of asymmetrical flow field-flow fractionation: Slot outlet technique Anal. Chem. 2006, 78, 6664-6669
28. Pauw, B. R. Everything SAXS: Small-angle scattering pattern collection and correction J. Phys.: Condens. Matter 2013, 25, 383201
29. Breßler, I.; Pauw, B. R.; Thünemann, A. F. McSAS Software for the retrieval of model parameter distributions from scattering patterns J. Appl. Cryst. 2015, 48, 962-969
30. Bolea, E.; Jimenez-Lamana, J.; Laborda, F.; Abad-Alvaro, I.; Blade, C.; Arola, L.; Castillo, J. R. Detection and characterization of silver nanoparticles and dissolved species of silver in culture medium and cells by AsFlFFF-UV-Vis-ICPMS: Application to nanotoxicity tests Analyst 2014, 139, 914-922
31. Huynh, K. A.; Chen, K. L. Aggregation kinetics of citrate and polyvinylpyrrolidone coated silver nanoparticles in monovalent and divalent electrolyte solutions Environ. Sci. Technol. 2011, 45, 5564-5571
32. Zook, J. M.; Long, S. E.; Cleveland, D.; Geronimo, C. L. A.; MacCuspie, R. I. Measuring silver nanoparticle dissolution in complex biological and environmental matrices using UV-visible absorbance Anal. Bioanal. Chem. 2011, 401, 1993-2002
33. Balmer, J. A.; Mykhaylyk, O. O.; Schmid, A.; Armes, S. P.; Fairclough, J. P. A.; Ryan, A. J. Characterization of polymer-silica nanocomposite particles with core-shell morphologies using Monte Carlo simulations and small angle X-ray scattering Langmuir 2011, 27, 8075-8089
34. Vonarbourg, A.; Passirani, C.; Saulnier, P.; Benoit, J. P. Parameters influencing the stealthiness of colloidal drug delivery systems Biomaterials 2006, 27, 4356-4373
35. Kittler, S.; Greulich, C.; Diendorf, J.; Koller, M.; Epple, M. Toxicity of silver nanoparticles increases during storage because of slow dissolution under release of silver ions Chem. Mater. 2010, 22, 4548-4554
36. Bohmert, L.; Hansen, U.; Girod, M.; Knappe, P.; Niemann, B.; Thunemann, A.; Lampen, A. Cytotoxicity of AgPure silver nanoparticles in the human intestinal cell line Caco-2 Toxicol. Lett. 2011, 205, S280-S280
37. Bouwmeester, H.; Poortman, J.; Peters, R. J.; Wijma, E.; Kramer, E.; Makama, S.; Puspitaninganindita, K.; Marvin, H. J. P.; Peijnenburg, A. A. C. M.; Hendriksen, P. J. M. Characterization of translocation of silver nanoparticles and effects on whole-genome gene expression using an in vitro intestinal epithelium coculture model ACS Nano 5, 4091-4103.
38. Smith, F. C. The Ultra-Violet Absorption Spectra of Certain Aromatic Amino-Acids, and of the Serum Proteins Proc. R. Soc. London., Ser. B 1929, 104, 198-205
39. Giddings, J. C. Field-flow fractionation - Analysis of macromolecular, colloidal, and particulate materials Science 1993, 260, 1456-1465
40. Ferrer, M. L.; Duchowicz, R.; Carrasco, B.; de la Torre, J. G.; Acuna, A. U. The conformation of serum albumin in solution: A combined phosphorescence depolarization-hydrodynamic modeling study Biophys. J. 2001, 80, 2422-2430
41. Gondikas, A. P.; Morris, A.; Reinsch, B. C.; Marinakos, S. M.; Lowry, G. V.; Hsu-Kim, H. Cysteine-induced modifications of zero-valent silver nanomaterials: Implications for particle surface chemistry, aggregation, dissolution, and silver speciation Environ. Sci. Technol. 46, 7037-45.
42. Wigginton, N. S.; Titta, A. d.; Piccapietra, F.; Dobias, J.; Nesatyy, V. J.; Suter, M. J. F.; Bernier-Latmani, R. Binding of silver nanoparticles to bacterial proteins depends on surface modifications and inhibits enzymatic activity Environ. Sci. Technol. 2010, 44, 2163-2168
43. Han, J.; Liu, Y.; Guo, R. Reactive template method to synthesize gold nanoparticles with controllable size and morphology supported on shells of polymer hollow microspheres and their application for aerobic alcohol oxidation in water Adv. Funct. Mater. 2009, 19, 1112-1117
44. Cedervall, T.; Lynch, I.; Foy, M.; Berggad, T.; Donnelly, S. C.; Cagney, G.; Linse, S.; Dawson, K. A. Detailed identification of plasma proteins adsorbed on copolymer nanoparticles Angew. Chem., Int. Ed. 2007, 46, 5754-5756
45. Gessner, A.; Waicz, R.; Lieske, A.; Paulke, B. R.; Mader, K.; Muller, R. H. Nanoparticles with decreasing surface hydrophobicities: Influence on plasma protein adsorption Int. J. Pharm. 2000, 196, 245-249
46. Cedervall, T.; Lynch, I.; Lindman, S.; Berggard, T.; Thulin, E.; Nilsson, H.; Dawson, K. A.; Linse, S. Understanding the nanoparticle-protein corona using methods to quantify exchange rates and affinities of proteins for nanoparticles Proc. Natl. Acad. Sci. U. S. A. 2007, 104, 2050-2055
47. Shannon, R. Revised effective ionic radii and systematic studies of interatomic distances in halides and chalcogenides Acta Crystallogr., Sect. A 1976, 32, 751-767
48. Stolnik, S.; Illum, L.; Davis, S. S. Long circulating microparticulate drug carriers Adv. Drug Delivery Rev. 1995, 16, 195-214
49. Gref, R.; Domb, A.; Quellec, P.; Blunk, T.; Muller, R. H.; Verbavatz, J. M.; Langer, R. The controlled intravenous delivery of drugs using PEG-coated sterically stabilized nanospheres Adv. Drug Delivery Rev. 1995, 16, 215-233
50. Florin, E.; Kjellander, R.; Eriksson, J. C. Salt effects on the cloud point of the poly(ethylene oxide) + water system J. Chem. Soc., Faraday Trans. 1 1984, 80, 2889-2910
51. Gradishar, W. J.; Tjulandin, S.; Davidson, N.; Shaw, H.; Desai, N.; Bhar, P.; Hawkins, M.; OShaughnessy, J. Phase III trial of nanoparticle albumin-bound paclitaxel compared with polyethylated castor oil based paclitaxel in women with breast cancer J. Clin. Oncol. 2005, 23, 7794-7803
52. Dell'Orco, D.; Lundqvist, M.; Oslakovic, C.; Cedervall, T.; Linse, S. Modeling the time evolution of the nanoparticle-protein corona in a body fluid PLoS One 5, 8.
53. Aggarwal, P.; Hall, J. B.; McLeland, C. B.; Dobrovolskaia, M. A.; McNeil, S. E. Nanoparticle interaction with plasma proteins as it relates to particle biodistribution, biocompatibility and therapeutic efficacy Adv. Drug Delivery Rev. 2009, 61, 428-437